US Physical Therapy (USPH) Gets a Hold Rating from Barrington

In a report released today, Michael Petusky from Barrington maintained a Hold rating on US Physical Therapy (NYSE: USPH). The company’s shares closed yesterday at $116.15, close to its 52-week high of $116.65.

Petusky noted:

“We are maintaining our MARKET PERFORM investment rating on USPH shares due to valuation concerns. This is genuinely frustrating because we continue to really like this business and its management team. That said, to hold a constructive investment rating on USPH shares, we would need to assign more than a 23.5x EV/EBITDA multiple to our 2019 estimate. As much as we like the company, such a valuation seems a bit much.”

According to TipRanks.com, Petusky is a 4-star analyst with an average return of 16.0% and a 62.9% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics Inc, Varian Medical Systems, and Merit Medical Systems.

The word on The Street in general, suggests a Hold analyst consensus rating for US Physical Therapy with a $103 average price target, a -11.3% downside from current levels. In a report released yesterday, Cantor Fitzgerald also reiterated a Hold rating on the stock with a $103 price target.

.

See today’s analyst top recommended stocks >>

The company has a one-year high of $116.65 and a one-year low of $56.50. Currently, US Physical Therapy has an average volume of 46.27K.

Based on the recent corporate insider activity of 46 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. It provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The company was founded in 1990 and is headquartered in Houston, TX.